T1	Participants 568 580	198 patients
T2	Participants 677 699	Ninety nine patients (
T3	Participants 871 883	99 (group B)
T4	Participants 698 707	(group A)
T5	Participants 1233 1240	group A
T6	Participants 1322 1329	group B
T7	Participants 1649 1656	group B
T8	Participants 1544 1551	group A
T9	Participants 1575 1582	group B
T10	Participants 1629 1636	group A
T11	Participants 1897 1904	group B
